Prevacid vs Lifestyle Modifications for the Treatment of LPR

Status Unknown status

Clinical Trial Summary

The purpose of this study is to evaluate changes in scores on the Reflux Finding Score and Reflux Symptom Index over a 24 week period. To enroll subjects must score at least a 13 on the Reflux Symptom Index and at least a 5 on the Reflux Finding Score. All subjects will receive education on lifestyle modifications with a nutritionist and exercise trainer. All subjects will be expected to comply with lifestyle modifications for the entire study period of 24 weeks. Half of all subjects will receive Prevacid 30mg BID and half will receive placebo BID for 24 weeks. Subjects will have 4 office visits over 24 weeks and weekly contacts with the study staff to assess Reflux Symptom Index and any health or medication changes.

Clinical Trial Description

The results of studies evaluating PPI therapy versus lifestyle modifications for the treatment of LPR have not been conclusive. However, many of these studies were conducted at tertiary care centers. We will look at patients presenting with LPR symptoms in a community setting. All subjects will have an exam of their larynx via laryngoscopy at each of the 4 study visits (screening, week 6, week 12, and week 24). Based on exam findings, the physician will complete the Reflux Finding Score. The subjects will also complete the Reflux Symptom Index weekly to assess for changes in their symptoms. The statistical analysis of this study will include evaluating changes in the Reflux Finding Scores and Reflux Symptom Index scores over the 24 weeks of study participation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00274339
Study type	Interventional
Source	Hodge, Kenneth M., M.D.
Contact	Marti Gardner, MSN
Phone	502-893-0159
Email	mgardner@commonwealthent.com
Status	Unknown status
Phase	N/A
Start date	December 2005
Completion date	June 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06205446` - Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction	N/A
Completed	`NCT02552966` - Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin	N/A
Completed	`NCT01450748` - Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux	Phase 3
Recruiting	`NCT04827355` - Reflux Band in Laryngopharyngeal Reflux	N/A
Not yet recruiting	`NCT03455803` - Effect of CPAP Therapy on LPR Among Patients With OSAS	N/A
Withdrawn	`NCT02530879` - Comparison of Voice Therapy and Antireflex Therapy in LPR	Phase 4
Completed	`NCT01854970` - Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux	N/A
Completed	`NCT00321503` - Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)	N/A
Terminated	`NCT01317472` - The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux	N/A
Completed	`NCT01880892` - Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy	N/A
Completed	`NCT02183961` - Three Methods Used in the Diagnosis of EER in Children With OME	N/A
Not yet recruiting	`NCT01328652` - Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy	Phase 4
Not yet recruiting	`NCT04383262` - Lexiva for the Treatment of LPR	Phase 3
Recruiting	`NCT04984304` - Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough	N/A
Withdrawn	`NCT03463395` - Efficacy of Reza Band for the Treatment of Laryngopharyngeal Reflux	N/A
Completed	`NCT00864396` - Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux	Phase 1
Completed	`NCT03619811` - Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease	N/A
Recruiting	`NCT05879029` - Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD	Phase 4
Recruiting	`NCT05204303` - LPR Fluorescence Pilot
Terminated	`NCT01777854` - Anti-reflux Control to Decrease Post Tonsillectomy Pain	Phase 4